Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer

CARMEN ALICIA PADILLA PEÑAJOSÉ ANTONIO BÁRCENA RUIZ2026-01-292026-01-29202010.1016/j.redox.2020.1015282-s2.0-85084235081https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/31701Organic ChemistryDownregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancerresearch article